Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects

Clinical trial NCT03719664 · UNKNOWN

Trial details

NCT number: NCT03719664
Sponsor: Frontier Biotechnologies Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2018-12-17
Primary completion: 2022-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.